Calà Giuseppe, Sina Beatrice, De Coppi Paolo, Giobbe Giovanni Giuseppe, Gerli Mattia Francesco Maria
Division of Surgery and Interventional Science, Department of Surgical Biotechnology, University College London, London, United Kingdom.
Stem Cell and Regenerative Medicine Section, Zayed Centre for Research into Rare Disease in Children, Great Ormond Street Institute of Child Health, University College London, London, United Kingdom.
Front Bioeng Biotechnol. 2023 Mar 3;11:1058970. doi: 10.3389/fbioe.2023.1058970. eCollection 2023.
During the past 10 years the world has experienced enormous progress in the organoids field. Human organoids have shown huge potential to study organ development, homeostasis and to model diseases . The organoid technology has been widely and increasingly applied to generate patient-specific 3D cultures, starting from both primary and reprogrammed stem/progenitor cells. This has consequently fostered the development of innovative disease models and new regenerative therapies. Human primary, or adult stem/progenitor cell-derived, organoids can be derived from both healthy and pathological primary tissue samples spanning from fetal to adult age. The resulting 3D culture can be maintained for several months and even years, while retaining and resembling its original tissue's properties. As the potential of this technology expands, new approaches are emerging to further improve organoid applications in biology and medicine. This review discusses the main organs and tissues which, as of today, have been modelled using primary organoid culture systems. Moreover, we also discuss the advantages, limitations, and future perspectives of primary human organoids in the fields of developmental biology, disease modelling, drug testing and regenerative medicine.
在过去十年中,类器官领域取得了巨大进展。人类类器官在研究器官发育、体内平衡以及模拟疾病方面显示出巨大潜力。类器官技术已被广泛且越来越多地应用于从原代和重编程的干/祖细胞生成患者特异性的三维培养物。这进而推动了创新疾病模型和新的再生疗法的发展。人类原代或成体干/祖细胞来源的类器官可以从从胎儿到成人的健康和病理原代组织样本中获得。由此产生的三维培养物可以维持数月甚至数年,同时保留并类似于其原始组织的特性。随着这项技术潜力的扩大,新的方法正在出现,以进一步改善类器官在生物学和医学中的应用。本综述讨论了截至目前已使用原代类器官培养系统进行建模的主要器官和组织。此外,我们还讨论了原代人类类器官在发育生物学、疾病建模、药物测试和再生医学领域的优势、局限性和未来前景。